Remote Patient Monitoring Market by Condition (Congestive Heart Failure, Diabetes, Chronic Obstructive Pulmonary Disease, Blood Pressure, and Mental Health), Components (Devices and Software) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

September 2016 | 130 pages | ID: R2530F35EDEEN
Allied Market Research

Abstracts

The Global Remote Patient Monitoring Market size was $703 million in 2015 and is expected to grow at a CAGR of 17.0% to reach $2,130 million by 2022. Remote patient monitoring (RPM) is a technology used to collect medical and health-related data from individuals at one location and electronically transmit it to a healthcare provider at another location. RPM is used to remotely monitor and analyze physiological parameters such as blood oxygen levels, vital signs, blood pressure, heart rate, and blood sugar, which improves the quality of care, quality of life, and allows early prediction of aggravations and exacerbations. This reduces the number of emergency department visits, and duration of hospitalization. This is attributed to the large undiagnosed patient population, improving access to healthcare systems, and a high risk of developing chronic disease due to rapid urbanization. In addition, the increase in incidences of chronic diseases, such as diabetes and COPD, are responsible for the high growth rate.
Chronic heart diseases, diabetes, and chronic respiratory diseases are the leading cause of mortality and morbidity in the world. Chronic care management accounts for 75% of the healthcare costs. The increase in prevalence of chronic conditions places an enormous financial burden on the caregivers. Here, RPM technologies comes into role play and identifies small changes in the patient’s physiological data and promote self-monitoring. Thus, it reduces the readmissions and prevents avoidable hospitalizations. Moreover, these technologies decrease a number of unnecessary trips to the doctor’s office and reduce travel-related expenses that are necessary to receive quality medical care. On the short- and long-term basis, by proper implementation, RPM technologies can expand access to quality healthcare, and save time and money.
According to WHO, the leading causes of deaths in 2012 were: cardiovascular diseases, respiratory diseases, including asthma and chronic obstructive pulmonary disease, and diabetes. These are the major four non-communicable diseases (NCDs) which were responsible for 82% of the deaths worldwide. Remote health monitoring technologies focus on serious, chronic conditions, such as congestive heart failure (CHF), pulmonary fibrosis, and diabetes, as they tend to result in repeated hospitalization.
The report covers the analysis of remote patient monitoring devices market based on conditions, components, and geography. Based on the conditions, the market is categorized into congestive heart failure (CHF), diabetes, chronic obstructive pulmonary disease (COPD), blood pressure, mental health, and others. Based on components, the market is divided into two segments devices and software. Based on geography, the remote patient monitoring industry is studied with respect to four major regions – North America (U.S., Canada, and Mexico); Europe (Germany, France, U.K., Italy, Spain, and Russia); Asia-Pacific (Japan, China, India, Australia, South Korea, and Taiwan); and LAMEA (Brazil, Turkey, Venezuela, Saudi Arabia, and Republic of South Africa). The report includes the revenue generated from the sales of these categories.
Global leaders, such as Boston Scientific Corporation, Nihon Kohden, Medtronic Inc., Johnson & Johnson, and Omron Healthcare, have adopted collaboration as a strategy for the growth in the RPM market. For instance, Medtronic collaborated with Qualcomm in May 2016 to improve the health outcomes for diabetic patients. The aim of this collaboration was to jointly develop future generation continuous glucose monitoring systems that are affordable and easy-to-use. This can be achieved owing to Medtronics market-leadership in diabetes management and Qualcomm Lifes expertise to develop reference designs for wireless and small integrated modules.
On July 27, 2016, Boston Scientific completed the acquisition of Cosman Medical, Inc. This acquisition helped Boston Scientific expand their product portfolio and provide more options for patients with chronic diseases.
The key players profiled in this report include Aerotel Medical Systems (1988) Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, General Electric Company, Nihon Kohden Corporation, Medtornic Plc, Masimo Corporation, Abbott Laboratories, Johnson and Johnson and Omron Corporation. Other players in the RPM market include A&D Company, Limited, Aipermon GmbH & Co. KG, Jawbone, Docobo Ltd., Microlife Corporation, Schiller AG, SHL Telemedicine, and Sorin Group.
The market would gain traction in the developing regions of Asia-Pacific, Africa, and Latin America. The large undiagnosed patient population, rapid urbanization, rise in disposable incomes, improved government funding towards healthcare, and growth in awareness about RPM technologies are key factors that constitute the steady market growth in these regions. However, there would be pressing concerns related to the cost of technologies, especially in third-world countries and in the developing countries, such as India and China.
The Russian remote patient monitoring industry is projected to grow at a high CAGR of 19.3% during the forecast period. The major factors, such as lack of awareness and issues pertaining to price constraints, restrain the growth of RPM market in this region. However, the presence of untapped market would boost the growth of the market. Also, the increase in focus of the RPM vendors on the emerging markets (such as APAC and LAMEA nations) is primarily set to contribute towards the growth of the market.

KEY BENEFITS

• The global remote patient monitoring report provides an extensive analysis the current trends and highlighting the market potential from 2014 to 2022, in terms of value.
• The market scenario is comprehensively analyzed with respect to the conditions and components.
• Comprehensive analysis of the patents and clinical trials is provided to determine the prevailing opportunities.
• Recent developments, key manufacturers, and the global remote patient monitoring market shares are listed in this report to analyze the competitive scenario of the market.
• In-depth analysis of the market based on geography gives an understanding of the regional market, which assists in strategic business planning.

REMOTE PATIENT MONITORING MARKET KEY SEGMENTS:
The global remote patient monitoring market segmentation is illustrated as follows:
By Condition

• Congestive Heart Failure (CHF)
• Diabetes
• Chronic Obstructive Pulmonary Disease (COPD)
• Blood Pressure
• Mental Health
• Others

By Component

• Devices
• Software

By Geography

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Taiwan
• Rest of Asia-Pacific
• LAMEA
• Brazil
• Turkey
• Venezuela
• Saudi Arabia
• Republic of South Africa
• Rest of LAMEA

Contents

CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
  1.4.1 Secondary research
  1.4.2 Primary research
  1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings
  3.2.1 Top investment pockets
  3.2.2 Top winning strategies
3.3 Government regulations
  3.3.1 U.S. FDA
  3.3.2 Europe CE Mark
  3.3.3 Ministry of Health, Labor and Welfare (MHLW)
3.4 Reimbursement scenarios
3.5 Clinical trials
3.6 Patent analysis
3.7 Porters Five Forces analysis
3.8 Market dynamics
  3.8.1 Drivers
    3.8.1.1 Rising incidence of chronic diseases
    3.8.1.2 Technological advancements
    3.8.1.3 Increase in out of pocket expenses
  3.8.2 Restraints
    3.8.2.1 Unstable reimbursement regulations
    3.8.2.2 Limited awarenesS
  3.8.3 Market Opportunities
    3.8.3.1 Lucrative opportunities in emerging markets
    3.8.3.2 Undifferntiated products

CHAPTER 4 WORLD REMOTE PATIENT MONITORING MARKET, BY CONDITION

4.1 Overview
  4.1.1 Market size and forecast
4.2 Congestive heart failure (CHF)
  4.2.1 Key market trends
  4.2.2 Key growth factors and opportunities
  4.2.3 Market size and forecast
4.3 Diabetes
  4.3.1 Key market trends
  4.3.2 Key growth factors and opportunities
  4.3.3 Market size and forecast
4.4 Chronic obstructive pulmonary disease (COPD)
  4.4.1 Key market trends
  4.4.2 Key growth factors and opportunities
  4.4.3 Market size and forecast
4.5 Blood pressure monitoring
  4.5.1 Key market trends
  4.5.2 Key growth factors and opportunities
  4.5.3 Market size and forecast
4.6 Mental health
  4.6.1 Key market trends
  4.6.2 Key growth factors and opportunities
  4.6.3 Market size and forecast
4.7 Others
  4.7.1 Key market trends
  4.7.2 Key growth factors and opportunities
  4.7.3 Market size and forecast

CHAPTER 5 WORLD REMOTE PATIENT MONITORING MARKET, BY COMPONENTS

5.1 Overview
  5.1.1 Market size and forecast
5.2 Devices
  5.2.1 Market size and forecast
5.3 Software
  5.3.1 Market size and forecast

CHAPTER 6 WORLD REMOTE PATIENT MONITORING MARKET, BY GEOGRAPHY

6.1 Overview
  6.1.1 Market size and forecast
6.2 North America
  6.2.1 Key market trends
  6.2.2 Key growth factors and opportunities
  6.2.3 Market size and forecast
  6.2.4 Market size and forecast
  6.2.5 U.S.
  6.2.6 Canada
  6.2.7 Mexico
6.3 Europe
  6.3.1 Key market trends
  6.3.2 Key growth factors and opportunities
  6.3.3 Market size and forecast
  6.3.4 Market size and forecast
  6.3.5 Germany
  6.3.6 France
  6.3.7 U.K.
  6.3.8 Italy
  6.3.9 Spain
  6.3.10 Russia
  6.3.11 Rest of Europe
6.4 Asia Pacific
  6.4.1 Key market trends
  6.4.2 Key growth factors and opportunities
  6.4.3 Market size and forecast
  6.4.4 Market size and forecast
  6.4.5 Japan
  6.4.6 China
  6.4.7 Australia
  6.4.8 India
  6.4.9 South Korea
  6.4.10 Taiwan
  6.4.11 Rest of Asia-Pacific
6.5 LAMEA
  6.5.1 Key market trends
  6.5.2 Key growth factors and opportunities
  6.5.3 Market size and forecast
  6.5.4 Market size and forecast
  6.5.5 Brazil
  6.5.6 Turkey
  6.5.7 Venezuela
  6.5.8 Saudi Arabia
  6.5.9 Republic of South Africa
  6.5.10 Rest of LAMEA

CHAPTER 7 COMPANY PROFILES

7.1 Aerotel Medical Systems (1988) Ltd.
  7.1.1 Company overview
  7.1.2 Company snapshot
  7.1.3 Operating business segments
  1.1.4 Key strategic moves & developments
7.2 Biotronik SE & Co. KG
  7.2.1 Company overview
  7.2.2 Company snapshot
  7.2.3 Operating business segments
  7.2.4 Key strategic moves & developments
7.3 Boston Scientific Corporation
  7.3.1 Company overview
  7.3.2 Company snapshot
  7.3.3 Operating business segments
  7.3.4 Business performance
  7.3.5 Key strategic moves & developments
7.4 General Electric Company
  7.4.1 Company overview
  7.4.2 Company snapshot
  7.4.3 Operating business segments
  7.4.4 Business performance
  7.4.5 Key strategic moves & developments
7.5 Nihon Kohden Corporation
  7.5.1 Company overview
  7.5.2 Company snapshot
  7.5.3 Operating business segments
  7.5.4 Business performance
  7.5.5 Key strategic moves & developments
7.6 Medtronic Plc
  7.6.1 Company overview
  7.6.2 Company snapshot
  7.6.3 Operating business segments
  7.6.4 Business performance
  7.6.5 Key strategic moves & developments
7.7 Masimo Corporation
  7.7.1 Company overview
  7.7.2 Company snapshot
  7.7.3 Operating business segments
  7.7.4 Business performance
  7.7.5 Key strategic moves & developments
7.8 Abbott Laboratories
  7.8.1 Company Overview
  7.8.2 Company Snapshot
  7.8.3 Operating business segments
  7.8.4 Business performance
  7.8.5 Key strategic moves & developments
7.9 Johnson and Johnson
  7.9.1 Company overview
  7.9.2 Company snapshot
  7.9.3 Operating business segments
  7.9.4 Business performance
  7.9.5 Key strategic moves & developments
7.10 Omron Corporation
  7.10.1 Company overview
  7.10.2 Company snapshot
  7.10.3 Operating business segments
  7.10.4 Business performance
  7.10.5 Key strategic moves & developments
Other players in the RPM market include (profiles not included in the report)
A&D Company, Limited
Aipermon GmbH & Co. KG
Jawbone
Docobo Ltd.
Microlife Corporation
Schiller AG
SHL Telemedicine
Sorin Group

List Of Tables

LIST OF TABLES

TABLE 1 CLINICAL TRIALS, REMOTE PATIENT MONITORING MARKET, 20142016
TABLE 1 PATENTS REGISTERED/APPROVED, BY COUNTRY (20102016)
TABLE 2 PATENTS REGISTERED/APPROVED WORLDWIDE, 20102016
TABLE 3 PATENTS REGISTERED/APPROVED, BY YEAR (20102016)
TABLE 4 PATENTS REGISTERED/APPROVED, BY COMPANY (20102016)
TABLE 1 WORLD REMOTE PATIENT MONITORING MARKET, BY CONDITION, 20142022 ($MILLION)
TABLE 2 CHF REMOTE PATIENT MONITORING MARKET, BY REGION, 20142022 ($MILLION)
TABLE 3 CHF REMOTE PATIENT MONITORING MARKET, BY REGION, 20142022 ($MILLION)
TABLE 4 COPD REMOTE PATIENT MONITORING MARKET, BY REGION, 20142022 ($MILLION)
TABLE 5 BLOOD PATIENT MONITORING REMOTE PATIENT MONITORING MARKET, BY REGION, 20142022 ($MILLION)
TABLE 6 MENTAL HELATH REMOTE PATIENT MONITORING MARKET, BY REGION, 20142022 ($MILLION)
TABLE 7 REMOTE PATIENT MONITORING MARKET OF OTHER CONDITIONS, BY REGION, 20142022 ($MILLION)
TABLE 8 WORLD REMOTE PATIENT MONITORING MARKET, BY COMPONENTS, 20142022 ($MILLION)
TABLE 9 REMOTE PATIENT MONITORING MARKET FOR DEVICE COMPONENTS, BY REGION, 20142022 ($MILLION)
TABLE 10 REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY REGION, 20142022 ($MILLION)
TABLE 11 WORLD REMOTE PATIENT MONITORING MARKET, BY REGION, 20142022 ($MILLION)
TABLE 12 NORTH AMERICA REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 13 NORTH AMERICA REMOTE PATIENT MONITORING MARKET, BY COMPONENTS, 20142022 ($MILLION)
TABLE 14 EUROPE REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 15 EUROPE REMOTE PATIENT MONITORING MARKET, BY COMPONENTS, 20142022 ($MILLION)
TABLE 16 ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 17 ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET, BY COMPONENTS, 20142022 ($MILLION)
TABLE 18 LAMEA REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 19 LAMEA REMOTE PATIENT MONITORING MARKET, BY COMPONENTS, 20142022 ($MILLION)
TABLE 20 AEROTEL: COMPANY SNAPSHOT
TABLE 21 AEROTEL: OPERATING SEGMENTS
TABLE 22 BIOTRONIK: COMPANY SNAPSHOT
TABLE 23 BIOTRONIK: OPERATING SEGMENTS
TABLE 24 BOSTON: COMPANY SNAPSHOT
TABLE 25 BOSTON: OPERATING SEGMENTS
TABLE 26 GE: COMPANY SNAPSHOT
TABLE 27 GE: OPERATING SEGMENTS
TABLE 28 NIHON KOHDEN: COMPANY SNAPSHOT
TABLE 29 NIHON KOHDEN: PRODUCTS
TABLE 30 MEDTRONIC: COMPANY SNAPSHOT
TABLE 31 MEDTRONIC: OPERATING SEGMENTS
TABLE 32 MASIMO:COMPANY SNAPSHOT
TABLE 33 MASIMO: OPERATING SEGMENTS
TABLE 34 ABBOTT: COMPANY SNAPSHOT
TABLE 35 ABBOTT: PRODUCTS
TABLE 36 JOHNSON & JOHNSON:COMPANY SNAPSHOT
TABLE 37 JOHNSON & JOHNSON: OPERATING SEGMENTS
TABLE 38 OMRON: COMPANY SNAPSHOT
TABLE 39 OMRON: OPERATING SEGMENTS

List Of Figures

LIST OF FIGURES

FIG. 1 TOP INVESTMENT POCKETS: WORLD REMOTE PATIENT MONITORING, BY CONDITION
FIG. 2 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (20132016)
FIG. 3 TOP WINNING STRATEGIES: NATURE AND TYPE
FIG. 1 PATENTS REGISTERED/APPROVED WORLDWIDE, 20102016
FIG. 2 PATENTS REGISTERED/APPROVED YEAR-WISE
FIG. 3 PATENTS REGISTERED/APPROVED, BY COMPANY (2010-2016)
FIG. 4 TOP IMPACTING FACTORS
FIG. 5 U.S. REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 6 CANADA REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 7 MEXICO REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 8 GERMANY REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 9 FRANCE REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 10 U.K. REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 11 ITALY REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 12 SPAIN REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 13 RUSSIA REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 14 REST OF EUROPE REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 15 JAPAN REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 16 CHINA REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 17 AUSTRALIA REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 18 INDIA REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 19 SOUTH KOREA REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 20 TAIWAN REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 21 REST OF ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 22 BRAZIL REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 23 TURKEY REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 24 VENEZUELA REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 25 SAUDI ARABIA REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 26 REPUBLIC OF SOUTH AFRICA REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 27 REST OF LAMEA REMOTE PATIENT MONITORING MARKET SIZE AND FORECAST
FIG. 28 BOSTON: REVENUE BY YEAR ($MILLION)
FIG. 29 BOSTON: REVENUE BY SEGMENT, 2015 (%)
FIG. 30 BOSTON: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 31 GE: REVENUE BY YEAR ($MILLION)
FIG. 32 GE: REVENUE BY SEGMENT, 2015 (%)
FIG. 33 GE: HEALTHCARE REVENUE BY SUB SEGMENT, 2015 (%)
FIG. 34 GE: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 35 NIHON KOHDEN: REVENUE BY YEAR ($MILLION)
FIG. 36 NIHON KOHDEN: REVENUE BY SEGMENT, 2015 (%)
FIG. 37 NIHON KOHDEN: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 38 MEDTRONIC: REVENUE BY YEAR ($MILLION)
FIG. 39 MEDTRONIC: REVENUE BY SEGMENT, 2015 (%)
FIG. 40 MEDTRONIC: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 41 MASIMO: REVENUE BY YEAR ($MILLION)
FIG. 42 MASIMO: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 43 ABBOTT: REVENUE BY YEAR ($MILLION)
FIG. 44 ABBOTT: REVENUE BY SEGMENT, 2015 (%)
FIG. 45 ABBOTT: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 46 JOHNSON & JOHNSON: REVENUE BY YEAR ($MILLION)
FIG. 47 JOHNSON & JOHNSON: REVENUE BY SEGMENT, 2015 (%)
FIG. 48 JOHNSON & JOHNSON: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 49 OMRON: REVENUE BY YEAR ($MILLION)
FIG. 50 OMRON: REVENUE BY SEGMENT, 2015 (%)
FIG. 51 OMRON: REVENUE BY GEOGRAPHY, 2015 (%)